BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21327682)

  • 1. Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.
    Kanatani I; Lin X; Yuan X; Manorek G; Shang X; Cheung LH; Rosenblum MG; Howell SB
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):979-90. PubMed ID: 21327682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL; Narayan P; Puett D
    Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive.
    Narayan P; Gray J; Puett D
    Mol Endocrinol; 2002 Dec; 16(12):2733-45. PubMed ID: 12456794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.
    Cheung LH; Zhao Y; Alvarez-Cienfuegos A; Mohamedali KA; Cao YJ; Hittelman WN; Rosenblum MG
    J Exp Clin Cancer Res; 2019 Jul; 38(1):332. PubMed ID: 31362764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents.
    Liu Y; Cheung LH; Hittelman WN; Rosenblum MG
    Mol Cancer Ther; 2003 Dec; 2(12):1341-50. PubMed ID: 14707275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex.
    Meehan TP; Harmon BG; Overcast ME; Yu KK; Camper SA; Puett D; Narayan P
    J Mol Endocrinol; 2005 Apr; 34(2):489-503. PubMed ID: 15821112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of a functional single-chain human chorionic gonadotropin-luteinizing hormone receptor ectodomain complex in insect cells.
    Fralish GB; Narayan P; Puett D
    Endocrinology; 2001 Apr; 142(4):1517-24. PubMed ID: 11250932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.
    Alvarez de Cienfuegos A; Cheung LH; Mohamedali KA; Whitsett TG; Winkles JA; Hittelman WN; Rosenblum MG
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cells.
    Liu Y; Cheung LH; Thorpe P; Rosenblum MG
    Mol Cancer Ther; 2003 Oct; 2(10):949-59. PubMed ID: 14578460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells.
    Gudermann T; Birnbaumer M; Birnbaumer L
    J Biol Chem; 1992 Mar; 267(7):4479-88. PubMed ID: 1311310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
    Rivero-Müller A; Vuorenoja S; Tuominen M; Wacławik A; Brokken LJ; Ziecik AJ; Huhtaniemi I; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):17-25. PubMed ID: 17363137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
    Bodek G; Vierre S; Rivero-Müller A; Huhtaniemi I; Ziecik AJ; Rahman NA
    Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
    Oberoi P; Jabulowsky RA; Bähr-Mahmud H; Wels WS
    PLoS One; 2013; 8(4):e61267. PubMed ID: 23573299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of complimentarity between monoclonal antibodies (MAbs) to human chorionic gonadotropin (hCG) and polyclonal antibodies to luteinizing hormone/hCG receptor (LH-R) and their use in better understanding hormone-receptor interaction.
    Jeyakumar M; Krishnamurthy HN; Dighe RR; Moudgal NR
    Recept Signal Transduct; 1997; 7(4):299-310. PubMed ID: 9633830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.
    Mohamedali KA; Cao Y; Cheung LH; Hittelman WN; Rosenblum MG
    Mol Cancer Ther; 2013 Oct; 12(10):2055-66. PubMed ID: 23858102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone receptor mRNA down-regulation is mediated through ERK-dependent induction of RNA binding protein.
    Menon B; Franzo-Romain M; Damanpour S; Menon KM
    Mol Endocrinol; 2011 Feb; 25(2):282-90. PubMed ID: 21147848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG).
    Viswanath G; Chatterjee S; Roy P
    Mol Cell Endocrinol; 2007 Jun; 272(1-2):14-21. PubMed ID: 17548147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.
    Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leutropin/beta-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface.
    Moyle WR; Bernard MP; Myers RV; Marko OM; Strader CD
    J Biol Chem; 1991 Jun; 266(17):10807-12. PubMed ID: 1645710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.